1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Anti-Infective Drug News 01 JUNE 2015

Anti-Infective Drug News 01 JUNE 2015

  • June 2015
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Gilead Will Be Seeking Further Candidates Following HBV Vaccine Failure
Industry Brief - Cempra Reports Phase III Data For Oral Solithromycin In CABP
Industry Brief - Consilient Launches Amoxicillin+Clavulanate In UK
Industry Trend Analysis - Dificlir/Dificid To Fall Behind As CDI Market Competition Increases
Industry Brief - Wockhardt's WCK 4873 Gains FDA QIDP Designation
Industry Brief - Cidara's CD101 IV Gains FDA QIDP/Fast Track Designations
Industry Brief - Claris Gains Fluconazole sANDA Approval
Industry Brief - Nix-TB Trial To Test All-Oral Regimen For XDR-TB Treatment
Industry Trend Analysis - Commercial Opportunity To Remain Limited In MDR-TB Despite Improved Access
Industry Trend Analysis - Merck To Create Impact In HCV Despite Late Entry
Industry Brief - Soligenix Enters Partnership To Develop Heat Stable Ebola Vaccine
Industry Trend Analysis - Senator's Actions Serve As A Warning But Will Not Succeed
Industry Brief - Visterra Partners With A*STAR to Develop Monoclonal Antibody For Dengue
Industry Brief - Genocea's Genital Herpes Immunotherapy Delivers Positive Top-Line Phase II Data
Industry Brief - FDA Amends Breakthrough Therapy Designation For BMS' Daclatasvir-Based HCV Regimen
Industry Trend Analysis - J&J To Enhance Position In HCV
Industry Brief - Daiichi Sankyo/Takeda Sign Sales Deals With Kaketsuken For Flu Vaccine
Industry Brief - Phase I Trial Of Prime-Boosted GSK Ebola Vaccine Candidate Initiated
Industry Brief - Bavarian Nordic Reports Positive Phase III Results For Its Smallpox Vaccine
Industry Brief - Mylan Launches Sovaldi In India
Industry Brief - Hemispherx' Ampligen Gains EU Orphan Designation For EVD
Industry Brief - Bavarian Nordic Secures EUR50mn Loan From EIB
Industry Trend Analysis - Aurobindo's Dolutegravir ANDA Will Ultimately Benefit ViiV And Improve Access
Industry Brief - J&J Expands Access To Darunavir
Industry Brief - EMA Validates Gilead's MAA For F/TAF-Based HIV Regimen
Industry Brief - FDA Licenses Protein Sciences' Flublok Manufacturing Facility
Industry Brief - UNC-Chapel Hill/GSK Enter Collaboration To Discover HIV Cure

Table Of Contents

Anti-Infective Drug News 01 JUNE 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market in New Zealand - Forecast

  • December 2016
    71 pages
  • Therapy  

  • New Zealand  

View report >

Insulin Market in the US

  • December 2016
    8 pages
  • Insulin  

  • United States  

View report >

Therapy Market in the UK

  • December 2016
    194 pages
  • Therapy  

    Infectious Dise...  

    Eye Disease  

  • United Kingdom  

View report >

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.